Literature DB >> 21702393

Implementation of a protocol to reduce occurrence of retained sponges after vaginal delivery.

Monica A Lutgendorf1, Lynnett L Schindler, James B Hill, Everett F Magann, John D O'Boyle.   

Abstract

BACKGROUND: Retained sponges (gossypiboma) following vaginal delivery are an uncommon occurrence. Although significant morbidity from such an event is unlikely, there are many reported adverse effects, including symptoms of malodorous discharge, loss of confidence in providers and the medical system, and legal claims.
OBJECTIVE: To report a protocol intended to reduce the occurrence of retained sponges following vaginal delivery.
METHODS: After identification of limitations with existing delivery room protocols, we developed a sponge count protocol to reduce occurrence of retained vaginal sponges. We report our experience at Naval Medical Center Portsmouth, a large tertiary care military treatment facility with our efforts to implement a sponge count protocol to reduce retained sponges following vaginal delivery.
CONCLUSIONS: With appropriate pre-implementation training, protocols which incorporate post-delivery vaginal sweep and sponge counts are well accepted by the health care team and can be incorporated into the delivery room routine.

Entities:  

Mesh:

Year:  2011        PMID: 21702393     DOI: 10.7205/milmed-d-10-00438

Source DB:  PubMed          Journal:  Mil Med        ISSN: 0026-4075            Impact factor:   1.437


  2 in total

1.  Retained surgical sponges: a descriptive study of 319 occurrences and contributing factors from 2012 to 2017.

Authors:  Victoria M Steelman; Clarissa Shaw; Laurel Shine; Abbey J Hardy-Fairbanks
Journal:  Patient Saf Surg       Date:  2018-06-29

2.  A Socio-Technical Exploration for Reducing & Mitigating the Risk of Retained Foreign Objects.

Authors:  Siobhán Corrigan; Alison Kay; Katie O'Byrne; Dubhfeasa Slattery; Sharon Sheehan; Nick McDonald; David Smyth; Ken Mealy; Sam Cromie
Journal:  Int J Environ Res Public Health       Date:  2018-04-10       Impact factor: 3.390

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.